aid: ashvattha-therapeutics
name: Ashvattha Therapeutics
description: 'Ashvattha Therapeutics is a clinical-stage biopharmaceutical company developing
  a new class of precision nanomedicines built on hydroxyl dendrimer therapeutics (HDTs),
  a platform exclusively licensed from Johns Hopkins University. Hydroxyl dendrimers
  traverse tissue barriers such as the blood-retinal and blood-brain barrier and are
  selectively taken up by activated cells in regions of inflammation, allowing known
  small-molecule drugs to be delivered intracellularly to diseased tissue with sustained
  effect and reduced off-target exposure. The company is advancing programs across
  ophthalmology, neurology, and inflammatory disease, led by migaldendranib (MGB),
  a first-in-class subcutaneously administered nanomedicine in Phase 2 development
  for diabetic macular edema and neovascular age-related macular degeneration, plus
  hydroxyl dendrimer PET imaging tracers such as [18F]OP-801. Founded by Jeffrey L.
  Cleland, Kannan Rangaramanujam, and Sujatha Kannan. Ashvattha publishes no public
  developer program, API, or machine-readable interface.'
url: https://raw.githubusercontent.com/api-evangelist/ashvattha-therapeutics/refs/heads/main/apis.yml
image: https://avttx.com/wp-content/uploads/2019/05/logo.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-07-31'
modified: '2026-07-31'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Nanomedicine
- Drug Development
- Clinical Trials
- Ophthalmology
- Neurology
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-31'
  status: minimal
  artifacts_added: 3
  pass: local-v1
common:
- type: DomainSecurity
  url: security/ashvattha-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/ashvattha-therapeutics-llms.txt
- type: Website
  url: https://avttx.com/
- type: About
  url: https://avttx.com/about/
- type: Technology
  url: https://avttx.com/technology/
- type: Pipeline
  url: https://avttx.com/pipeline/
- type: Blog
  name: News
  url: https://avttx.com/news/
- type: BlogRSS
  name: News RSS
  url: https://avttx.com/feed/
- type: Resources
  url: https://avttx.com/resources/
- type: Careers
  url: https://avttx.com/careers/
- type: Contact
  url: https://avttx.com/contact/
- type: PrivacyPolicy
  url: https://avttx.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/ashvattha-therapeutics-inc
- type: SecondaryMarket
  name: Forge Global listing
  url: https://forgeglobal.com/ashvattha-therapeutics_stock/